Companies: 10,795·Total market cap: $144.5T
Entera Bio Ltd.

Entera Bio Ltd.

ENTXNASDAQHealthcare● Active
$1.22
+$0.02(+1.67%)
Market Cap$60134044
P/E Ratio
52W High$3.22
52W Low$0.91
Overview

Entera Bio Ltd. (ENTX) Revenue

Annual & quarterly revenue history · segment & region breakdown

ENTX · revenue · updated Jun 9, 2026

Core revenue metrics

Entera Bio Ltd. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
18 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Entera Bio Ltd. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
ENTX revenue by year · ENTX revenue history · ENTX annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Entera Bio Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Entera Bio Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Entera Bio Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

ENTX revenue · 4 questions

ENTX's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

ENTX revenueENTX annual revenuewhat is ENTX revenueENTX TTM revenue

Source: FMP · Entera Bio Ltd. SEC filings · GAAP · Entera Bio Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026